[HTML][HTML] Cost-effectiveness analysis of out-of-hospital versus in-hospital extracorporeal cardiopulmonary resuscitation for out-hospital refractory cardiac arrest

D Al-Badriyeh, AA Hssain, D Abushanab - Current Problems in Cardiology, 2022 - Elsevier
It has been speculated that out-of-hospital cardiac arrest (OHCA) patients' survival might be
improved by implementing extracorporeal cardiopulmonary resuscitation (ECPR) before …

Applications of machine learning in chronic myeloid leukemia

M Elhadary, AA Elsabagh, K Ferih, B Elsayed… - Diagnostics, 2023 - mdpi.com
Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm characterized by
dysregulated growth and the proliferation of myeloid cells in the bone marrow caused by the …

[HTML][HTML] SARS-CoV-2 Omicron variant in patients with chronic myeloid leukemia: a retrospective study

EA Ali, I Khamees, M Abu-Tineh, H Qasim, A Alshurafa… - Cureus, 2022 - ncbi.nlm.nih.gov
Materials and methods Retrospective data from the records of the National Center for
Cancer Care and Research from December 20, 2021, to January 30, 2022. Participants …

Cost‑effectiveness of add‑on dapagliflozin for heart failure with reduced ejection fraction patients without diabetes

D Abushanab, S Chbib, R Kaddoura… - Journal of Medical …, 2024 - Taylor & Francis
Aim To evaluate the cost-effectiveness of dapagliflozin added to standard of care (SoC)
versus SoC in heart failure with reduced ejection fraction (HFrEF) and without type 2 …

[HTML][HTML] Avascular necrosis in patients with chronic myeloid leukemia: A systematic review

AF Al-Mashdali, HN Al-Dubai… - Acta Bio Medica: Atenei …, 2022 - ncbi.nlm.nih.gov
Objective: Avascular necrosis (AVN) has been encountered in hematological malignancies;
nonetheless, AVN is extremely uncommon in patients with chronic myeloid leukemia (CML) …

[HTML][HTML] Myasthenia Gravis and Myeloproliferative Neoplasms–Mere Association or Paraneoplastic Neurologic Syndrome: A Mini-Review

S Sasi, M Mohamed, P Chitrambika… - Acta Bio Medica: Atenei …, 2021 - ncbi.nlm.nih.gov
Myasthenia Gravis (MG) is a rare neurological condition characterized by muscle weakness
that worsens after use. Myeloproliferative Neoplasms (MPNs) are disorders due to stem-cell …

[HTML][HTML] Tumor lysis syndrome in the chronic phase of chronic myeloid leukemia following COVID-19 infection: a case report

AHW Hajjar, S Abbarh, A Al-Mashdali, A Alshurafa… - Cureus, 2022 - ncbi.nlm.nih.gov
Tumor lysis syndrome (TLS) is a hematological emergency. This syndrome is characterized
by metabolic derangements such as hyperkalemia and hypocalcemia, which result from …

[HTML][HTML] Dasatinib-Induced Colitis with Rectal Sparing in a Patient with Chronic Myeloid Leukemia (Chronic Phase) on Dasatinib as an Upfront Therapy: Case Report

Z Maat, K Mushtaq, MA Yassin - Case Reports in Oncology, 2022 - karger.com
Dasatinib is a BCR-ABL tyrosine kinase inhibitor which was approved in 2006 for the
treatment of adults diagnosed with Philadelphia chromosome-positive (Ph+) chronic myeloid …

[HTML][HTML] Coexistence of prefibrotic myelofibrosis with monoclonal gammopathy of undetermined significance: a case report

OM Ismail, A Amer, FA Ibrahim, M Abu-Tineh… - Case Reports in …, 2022 - karger.com
The coexistence of dual hematological neoplasms is an unusual and challenging
presentation due to the different combination of etiopathology. The presentation of …

[HTML][HTML] Osteolytic bone lesions in patients with primary myelofibrosis: a systematic review

NG Battikh, EAAH Ali, MA Yassin - Blood, 2021 - Elsevier
Abstract Background: Philadelphia negative Myeloproliferative neoplasms classically
characterized by excess production of terminal myeloid cells in the peripheral blood. Among …